Isoprostane
|
WikiDoc Resources for Isoprostane |
|
Articles |
|---|
|
Most recent articles on Isoprostane Most cited articles on Isoprostane |
|
Media |
|
Powerpoint slides on Isoprostane |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Isoprostane at Clinical Trials.gov Clinical Trials on Isoprostane at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Isoprostane
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Isoprostane Discussion groups on Isoprostane Patient Handouts on Isoprostane Directions to Hospitals Treating Isoprostane Risk calculators and risk factors for Isoprostane
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Isoprostane |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
The isoprostanes are prostaglandin-like compounds formed in vivo from the free radical-catalyzed peroxidation
of essential fatty acids (primarily arachidonic acid) without the direct action of cyclooxygenase (COX) enzyme.
[1][2]
These nonclassical eicosanoids possess potent biological activity as inflammatory mediators that augment the perception of pain.[3] These compounds are accurate markers of lipid peroxidation in both animal and human models of oxidative stress.
Abundance
| “ | Polyunsaturated fatty acids other than arachidonic acid are also vulnerable to reactive oxygen species and produce isoprostanes.
For example, in addition to the four classes of F2-isoprostanes that can arise from arachidonic acid, peroxidation of eicosapentaenoic acid (EPA) is predicted to lead to the generation of six classes of F3 isoprostanes, α-linolenic and γ-linolenic acids to two classes of E1- and F1-isoprostanes, and docosahexaenoic acid to eight classes of D4-isoprostanes and eight classes of E4-isoprostanes. Each of the classes comprise up to eight racemic isomers, leading to an astounding number of isoprostane molecules! |
” |
—LJ Janssen[4] | ||
References
- ↑ COX activity produces H2O2 which may non-enzymatically produce isoprostanes.
- ↑
Morrow JD, Roberts LJ (1996). "The isoprostanes. Current knowledge and directions for future research". Biochem. Pharmacol. 51 (1): 1–9. PMID 8534261.
|access-date=requires|url=(help) - ↑ Evans AR, Junger H, Southall MD; et al. (2000). "Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons". J. Pharmacol. Exp. Ther. 293 (3): 912–20. PMID 10869392.
- ↑ Janssen LJ (2001). "Isoprostanes: an overview and putative roles in pulmonary pathophysiology". Am. J. Physiol. Lung Cell Mol. Physiol. 280 (6): L1067–82. PMID 11350785. Retrieved 2007-11-02.